CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 4 Grant or award Global Head of R&D acquired 0 shares (grant or award)
- 4 Grant or award President, COO & GM China acquired 0 shares (grant or award)
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $278.14 ($417,211)
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Material agreement · Other events
- 4 Open-market sale CMO, Hematology sold 1,049 shares at an average $359.86 ($377,493)
- 424B5 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- 424B5 Offering Prospectus
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $381.34 ($572,003)
- 8-K Event Results of operations · Other events
- 4 Open-market sale Director sold 4,500 shares at an average $350.04 ($1,575,202)
- 4 Open-market sale Director sold 4,500 shares at an average $349.81 ($1,574,148)
Page 32 of 64 · 1,278 filings